en
Scientific article
Review
Open access
English

Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis

Published inDiagnostics, vol. 12, no. 7, 1665
Publication date2022-07-08
First online date2022-07-08
Abstract

Background: Several studies proposed the use of positron emission tomography (PET) with Prostate Specific Membrane Antigen (PSMA)-targeting radiopharmaceuticals in brain tumors. Our aim is to calculate the diagnostic accuracy of these methods in high-grade gliomas (HGG) with a bivariate meta-analysis.

Methods: A comprehensive literature search of studies on the diagnostic accuracy of PET/CT or PET/MRI with PSMA-targeting radiopharmaceuticals in HGG was performed. Original articles evaluating these imaging methods both in the differential diagnosis between HGG and low-grade gliomas (LGG) and in the assessment of suspicious HGG recurrence were included. Pooled sensitivity, specificity, positive and negative likelihood ratios (LR+ and LR-), and diagnostic odds ratio (DOR) including 95% confidence intervals (95% CI) were calculated. Statistical heterogeneity was also assessed using the I2test.

Results: The meta-analysis of six selected studies (157 patients) provided the following results about PET/CT or PET/MRI with PSMA-targeting radiopharmaceuticals in the diagnosis of HGG: sensitivity 98.2% (95% CI: 75.3-99.9%), specificity 91.2% (95% CI: 68.4-98.1%), LR+ 4.5 (95% CI: 2.2-9.3), LR- 0.07 (95% CI: 0.04-0.15), and DOR 70.1 (95% CI: 19.6-250.9). No significant statistical heterogeneity among the included studies was found (I2= 0%).

Conclusions: the quantitative data provided demonstrate the high diagnostic accuracy of PET/CT or PET/MRI with PSMA-targeting radiopharmaceuticals for HGG detection. However, more studies are needed to confirm the promising role of PSMA-targeted PET in this clinical setting.

eng
Keywords
  • PET
  • PSMA
  • Brain tumors
  • Glioblastoma
  • Glioma
  • Meta-analysis
  • Neuro-oncology
  • Nuclear medicine
  • Positron emission tomography
Citation (ISO format)
MUOIO, Barbara et al. Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis. In: Diagnostics, 2022, vol. 12, n° 7, p. 1665. doi: 10.3390/diagnostics12071665
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
ISSN of the journal2075-4418
31views
11downloads

Technical informations

Creation01/03/2023 12:48:56 PM
First validation11/07/2023 8:16:24 AM
Update time11/07/2023 8:16:24 AM
Status update11/07/2023 8:16:24 AM
Last indexation05/06/2024 5:17:27 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack